EPIDEMIOLOGY
Just a few decades ago, every venous cannulation was something of an adventure for hospitalized patients. Steel "butterfly" needles posed little infection risk but provided relatively insecure venous access and had to be changed frequently. Short plastic cannulae were more reliable, but these stiff, thick-walled polyvinyl chloride devices were associated with high rates of phlebitis, local infection, and bacteremia (62, 69, 105, 107, 108, 112, 130) . When peripheral veins in the arm were exhausted, physicians often resorted to a venous "cut down" or femoral venous catheterization, both of which were associated with infection risks that would be considered intolerable today (8, 129) . Patients were also at risk for septicemia caused by contaminated intravenous fluids, although the medical community was largely unaware of this problem until the early 1970s, when a nationwide epidemic of infusion-related infection was traced to contamination of fluids at the time of manufacture (58, 103, 114, 115, 149, 166) .
The past decade has witnessed impressive technological advances in intravenous therapy. Improved manufacturing practices for large-volume parenteral fluids have substantially reduced the risk of contamination. There have also been remarkable improvements in catheter design and materials. Stiff, relatively thrombogenic and infection-prone materials, such as polyvinyl chloride, have been largely replaced by smoother, more pliable, considerably less reactive plastics such as Teflon and silicon elastomer. Central venous catheters can be left in place for months and even years with acceptable complication rates (see below). Thus, patients who would have died of malnutrition in years past can now be supported indefinitely by intravenous infusions. Conditions that used to require lengthy hospitalizations for intravenous therapy can now be treated safely in the home. It is in this context that the current risk of infusion-related infection must be judged. 80 81 82 83 84 85 86 hospital to hospital (134) . For example, among 21 pediatric ICUs, incidence ranged from <3 to 27 central line-associated bacteremias per 1,000 central-line days. Adequate studies to determine whether these remarkable statistics reflect differences in the severity of illness of patients cared for in these units or variations in infection control practices and quality of care have not been performed. In fact, such interhospital comparisons of nosocomial infection rates, which have been advocated and pilot tested by the Joint Commission on Accreditation of Health Care Organizations (91) , must be interpreted with extreme caution because existing surveillance data are inadequate to permit adjustment for potential confounding variables. The significance of failing to adjust infection rates for confounding variables, such as severity of illness, catheter type, and the specific infusion therapy being administered, is discussed in greater detail below.
There has been a gradual change in the spectrum of pathogens isolated from patients with infusion-related bacteremia. The negative staphylococci (principally Staphylococcus epidermidis), and enterococci, has increased significantly. For example, in large NNIS teaching hospitals, the incidence of bacteremia caused by coagulase-negative staphylococci increased by 754% between 1980 and 1989, and the incidence of S. aureus and enterococcal bacteremia increased by 176 and 120%, respectively (11) . In addition, the incidence of primary bloodstream infection caused by Candida spp. increased in all hospital types, with the greatest increase (487%) occurring in large teaching hospitals. This trend is particularly alarming since hospital-acquired candidemia is associated with an attributable mortality rate of 38% and an excess length of hospital stay of 30 days (193) . In contrast, the incidence of primary gram-negative rod bacteremia in teaching hospitals has been virtually unchanged over the 10-year period. Although these trends have been attributed to increased use of intravascular catheters and decreased contamination of parenteral fluids, the explanation probably is much more complex, with changes in the patient population, hospital environment, and medical practice as well as in the microbes themselves all playing a role.
SOURCES OF MICROORGANISMS CAUSING INFUSION-RELATED INFECTIONS
Contaminated Infusion Systems The infusion system is vulnerable to microbial invasion via numerous routes: intrinsic contamination of infusate during manufacture; contamination of additives, piggyback infusions (including blood products), or in-line injectables; cracks in intravenous bottles or punctures in intravenous bags; attachment of bags or bottles to administration sets; changes of administration sets; manipulation of stop cocks, connections, and filters; retrograde contamination of fluid from contaminated catheters; and violation of system integrity to obtain blood or to irrigate occluded cannulae (70, 105, 112) . Fastidious technique must be used when setting up or manipulating intravenous systems or preparing intravenous solutions for administration. Introduction of even small numbers of microorganisms can have dire consequences, because intravenous fluids provide a surprisingly hospitable environment for the growth of many pathogens. Knowledge of which solutions support the growth of which specific pathogens is crucial for epidemiological investigations and clinical decisions. For example, Klebsiella, Enterobacter, and Citrobacter species proliferate rapidly in 5% dextrose in water at room temperature despite this solution's acidic pH and lack of nutrients, whereas staphylococci, Escherichia coli, Pseudomonas aenrginosa, Acinetobacter spp., and Candida spp. do not (114) . Pseudomonads are able to grow in particularly adverse environments, including distilled water, normal (0.9%) sodium chloride, and even iodophor antiseptics (12, 60, 84, 104) . Candida spp. grow well in protein hydrolysate solutions but much less vigorously in the synthetic amino acid mixtures used for hyperalimentation today (61) ; bacterial growth generally is suppressed in synthetic amino acid solutions. Lipid emulsion supports the rapid growth of a wide variety of bacterial and fungal pathogens, including Candida (35, 55, 126) and Malassezia spp., especially Malassezia furfur (6, 100, 155) .
Except for a few little publicized clusters of infection, the dangers of intravenous fluid contamination were largely ignored until 1970 to 1971, when a massive nationwide epidemic of infusion-related septicemia was traced to 5% dextrose in water produced by a single manufacturer (103, Whether intravenous fluid manufacturers have immunized themselves against future contamination problems remains to be seen, but in-use contamination of infusion systems remains a threat. Fortunately, careful handling of infusion systems is so well integrated into standard nursing practice that contamination of in-use fluids occurs very rarely (7, 17) . When contaminants are detected, they tend to be microorganisms of low virulence that do not proliferate readily in intravenous solutions. Accordingly, expensive recommendations that intravenous administration sets should be changed every 24 h to preclude excessive buildup of contaminants have been relaxed to permit changes every 48 to 72 h (7, 17, 18, 63, 110, 177 While sporadic epidemics due to contaminated infusions undoubtedly will continue to occur, the vast majority of endemic infusion-related infections are. caused by catheter contamination (62, 69, 105, 107, 108, 112) . Despite the passage of time, a much reproduced drawing by Maki still serves to summarize the principal routes by which microorganisms are believed to reach the catheter (Fig. 3) (107) . However, investigators from Barcelona, Spain, have suggested that this figure omits an additional route of catheterrelated infection: contamination of the catheter hub (45, 99, 175) . In one study of 135 subclavian catheters, 14 (70%) of 20 episodes of bacteremia were thought to have originated from a contaminated hub, with secondary colonization of the catheter tip (99) . In an earlier report, an outbreak of bacteremia caused by coagulase-negative staphylococci was attributed to manipulation of colonized hubs by the nursing staff (175) . Problems at the junction of the administration tubing and catheter hub may have contributed to two other clusters of bacteremia caused by coagulase-negative staphylococci (39, 142 Since catheter hubs have been cultured systematically in very few studies, the relative importance of hub contamination is unclear. However, Maki's group has suggested that hub contamination plays a minor role. In an investigation of pulmonary artery Swan-Ganz catheters, positive hub cultures were found in only 7% of catheters (127) . In another study of central venous and arterial catheters, the rate of hub colonization ranged from 1.9 to 5.7% (117) .
Additional studies of hub contamination clearly are warranted, but the data presented so far have done little to alter the consensus that most infusion-related infections result from contamination of the catheter itself during insertion and subsequent care. A considerable body of epidemiological and microbiological data suggests that microorganisms at the insertion site track into the catheter wound and quickly colonize the intravascular segment of the catheter. Migration of bacteria down the external surface of the catheter can occur with startling speed (33), suggesting that the fate of many catheters is sealed the moment they are inserted. The origins of these microorganisms are diverse (Fig. 3) . In some cases, the organisms are inoculated directly onto the insertion site by the application of contaminated antiseptic. As noted previously, pseudomonads can survive in the iodophor antiseptics that are in widespread use today (12, 60, 84) , but contamination of antiseptics was an even greater problem in the past, when insertion sites were prepared with agents such as aqueous benzalkonium chloride, which supported the growth of many gram-negative pathogens (41, 51) . Microorganisms can also be transported to the catheter wound by the contaminated hands of hospital personnel, who often fail to stop at the sink even when caring for high-risk patients in ICUs (1, 64 While all of these routes of catheter contamination are noteworthy, none rivals the importance of the patient's own cutaneous flora at the catheter insertion site. It is no accident that coagulase-negative staphylococci, the principal components of normal skin flora, are recovered so frequently from colonized catheters and patients with catheter-related bloodstream infections. Most investigators have found an excellent correlation between the results of cultures of insertion sites and cultures of catheters (5, 13, 178, 195) . For example, Snydman et al. found that the results of skin cultures taken within 1 week prior to removal of catheters used for total parenteral nutrition were highly predictive of the results of semiquantitative catheter cultures (predictive value of a negative skin culture = 98%; predictive value of a positive culture = 61%) (178) . In every case of significant catheter colonization, at least one of the organisms found on the catheter was also present at the skin site. Similarly, Armstrong et al. reported that catheter infection (defined by semiquantitative catheter culture) was highly correlated with a positive insertion site culture (relative risk = 4.5) (5), and Bjornson et al. documented an association between catheter colonization and growth of > 10 CFU from cultures of the insertion site (13) . By using stepwise logistic regression (120), Maki and Will found that heavy skin colonization was associated with both central venous catheter infection (odds ratio = 9.5) and bacteremia (odds ratio = 9.2). Positive skin cultures also are associated with colonization of peripheral intravenous catheters (116) . Although none of these investigators used the molecular techniques required to prove that strains isolated from skin and catheter were identical, plasmid profiles of S. epidermidis isolates from the skin and bloodstream of critically ill neonates were similar in one study (189) .
Additional support for the theory that microorganisms generally contaminate the intravascular catheter segment by migrating from the skin into the catheter wound comes from microbiological studies of the surface of colonized cannulae. If this hypothesis is correct, then the microorganisms responsible for catheter infection and bacteremia should be found primarily on the external surface of the catheter. Quantitative cultures of the catheter surface might be expected to predict which catheters are truly infected and are likely to spawn bloodstream infections. Indeed, Maki et al. have demonstrated that catheter-associated infections can be diagnosed relatively simply by rolling the intravascular or intracutaneous segment of the catheter across an agar plate and counting the resulting number of colonies (118) . In Maki's studies, growth of > 15 colonies was associated with bacteremia in 10 to 14% of cases (118) , whereas growth of <15 colonies or isolation of microorganisms only by nonquantitative broth culture of catheters rarely indicated that the catheter was responsible for bacteremia. Numerous investigators have studied more cumbersome catheter culture techniques, including quantitative cultures of sonicated, vortexed, rinsed, or flushed catheters and Gram stain of impression smears (16, 27-30, 148, 170) , but Maki's method remains in wide use because of its simplicity and relatively good predictive values. However, one novel approach deserves mention. Cooper and Hopkins noted that catheters colonized with significant numbers of organisms by Maki's criteria could be identified expeditiously by Gram staining the external surface of the catheter (sensitivity = 100%; specificity = 97%) (32). In only 4 of 41 colonized catheters were microorganisms visualized on the internal surface of the catheter by Gram stain, and in all of these cases, far greater numbers of microorganisms were present on the external surface. Acridine orange staining of catheter tips may also be used to detect catheter colonization directly (34, 198) .
Since growth of microorganisms on the skin is so critical to the pathogenesis of catheter-associated infection, it is hardly surprising that so many new products and techniques have been designed either to reduce the microbial burden at the insertion site or to interdict the migration of microorganisms into the catheter wound. Many of the studies that have tested the efficacy of these innovations have provided additional evidence of the role of skin flora in catheter colonization and infection.
At least one of these technological "advances" apparently has misfired. Semipermeable transparent dressings, although considerably more expensive than gauze, were thought to be worth the cost because they would facilitate frequent inspection of the catheter site for signs of inflammation without removal of the dressing. Although initial trials suggested that transparent dressings could be left in place for a week or more if no inflammation was detected, most studies have found that transparent dressings promote microbial growth on the underlying skin, which in turn is associated with an increased risk of catheter colonization (75, 186 (109, 138, 197) . However, there has been concern that such topical antibiotics might encourage the overgrowth of Candida spp. Povidone-iodine, which remains in widespread use, was marginally effective in one study (109) (117) . The superiority of the chlorhexidine preparation was attributed to its broad-spectrum antimicrobial properties and its prolonged residual activity on the skin. (187) , and loading of polyurethane catheters with a hydrophilic coating with teichoplanin has eliminated adherent bacteria from the catheter surface in vitro (86) . In a recent randomized trial in humans, Kamal et al. found that catheters treated with a cationic surfactant and then dipped in cefazolin (an anionic antibiotic) were associated with a 2% rate of colonization compared with a 14% rate of colonization with untreated catheters (89) . Unfortunately, the control catheters were not treated with surfactant, so the independent effect of the cefazolin is unclear. Moreover, cefazolin would be ineffective against oxacillin-resistant staphylococci, which are prevalent in many ICUs. Maki et al. have attempted to overcome the disadvantage of using a narrowspectrum antibiotic by testing a catheter impregnated with silver sulfadiazine and chlorhexidine gluconate (119 (169) , through the catheter, but this strategy seems foolhardy, since it would provide selective pressure for the further emergence of vancomycin resistance among nosocomial gram-positive cocci.
As shown in Fig. 3 , one additional mechanism of catheter colonization requires consideration: hematogenous seeding of the catheter tip by bacteremia from a distant site of infection. Catheter colonization is thought to be facilitated by the presence of a fibrin sheath that develops on the intravascular surface of the catheter shortly after insertion (79, 95, 105, 120, 147, 148, 182, 190 (67) . Both SNAP and NTISS predict mortality risk very well, and both improve prediction models based on birth weight alone.
Although the utility of these severity scoring systems in predicting mortality is widely acknowledged, it is important to recognize that their abilities to predict other adverse outcomes of hospitalization, such as catheter-associated infection, remain virtually unknown. Only one published study has examined the correlation between a severity scoring system and nosocomial infection risk (151). Pollack et al., in Toronto, Ontario, Canada, demonstrated that pediatric ICU patients with a PRISM score of >10 on admission were three times more likely to develop a nosocomial infection than children with lower scores (10.8 versus 3.4%). The hazard of comparing hospital infection rates without adjusting for severity of illness is all too clear, as demonstrated by the NNIS data on catheter-associated bacteremias mentioned above (134) . For example, the NNIS investigators suggested that the wide disparity in ICU bacteremia rates that they documented required a careful examination of practices and procedures in individual units. However, these infection rates were not adjusted for under-lying severity of illness or even for specific types of central catheters. Neonatal ICU infection rates were only crudely stratified by birth weight (1,500 g) despite abundant evidence that risk increases dramatically and progressively only at birth weights below 1,500 g (54, 59) .
While concentrating on the role of the catheter itself in the pathogenesis of infusion-related infection, investigators have tended to overlook the influence of the therapy delivered through the catheter on the risk of infection. Sometimes the effect is so dramatic that it is recognized with ease. For example, when 12 of 107 patients receiving interleukin-2 therapy for cancer developed central venous catheter-associated bacteremia, Snydman's group quickly realized that this rate of infection was considerably greater than the incidence of bacteremia in the ICU (4.1%), among patients with solid tumors (1.9%), or among patients receiving total parenteral nutrition (2.8%) (179) . A strong association of S. aureus bacteremia with preceding S. aureus colonization of the catheter site and interleukin-2-associated skin desquamation was noted. Other investigators have confirmed the increased risk of infection in patients receiving interleukin-2 via central venous catheters (14, 173) .
The effect of concomitant therapy is not always so dramatic. For example, many investigators have maintained that the use of intravascular catheters, particularly central venous lines, is the major risk factor for bacteremia caused by coagulase-negative staphylococci in neonates (42, 96, 133) . However, central catheters are used primarily in very low-birth-weight babies with prolonged hospitalizations in neonatal ICUs. After adjusting for these potential confounding variables, some groups could not confirm that the catheters themselves were independently associated with coagulase-negative staphylococcal bacteremia (48, 167) . Instead, they demonstrated that the types of intravenous fluids administered to the babies were associated with infection. Recently, our own group performed a case control study in infants in our neonatal ICU, matching infants by birth weight and duration of exposure to the unit (53). We found that central venous catheters indeed were associated with coagulase-negative staphylococcal bacteremia (odds ratio = 3.5), but since central lines were used infrequently in the ICU, only 15% of bacteremias could be attributed directly to these catheters. In addition, we noted that intravenous infusions of lipid were independently associated with coagulase-negative staphylococcal bacteremia (odds ratio = 5.8), and since many babies received lipids, the attributable risk for lipids was 57%. Moreover, the risk of bacteremia was constant regardless of when lipids were administered during hospitalization, and the risk increased linearly with increasing duration of lipid infusion. Since pharmacy and ICU practices virtually precluded frequent contamination of the lipid, we hypothesized that infusion of lipid ignited the proliferation of bacteria that had already been deposited on the catheter, ultimately leading to bacteremia. The risk of bacteremia may also have been potentiated by the tendency of lipids to block flow through the catheter (143) and to impair the functions of neutrophils and macrophages (47) .
An analogous situation may be found in the high rate of Malassezia furfur fungemia in neonates and older patients receiving lipids (6, 100, 155 (188) . In a recent study of more than 2,000 short peripheral Teflon and polyurethane catheters, Maki (52, 146) . Seen under the electron microscope, the surfaces of commercial catheters are far from perfect, and staphylococci tend to nestle in pits and crevices (Fig. 4) (52) . Many investigators have postulated that extracellular slime is the specific adhesin responsible for this attachment of coagulase-negative staphylococci to plastic biomaterials. However, slime is not seen in electron micrographs taken very early in the colonization process and is more likely to be involved in persistence of staphylococci on the catheter surface than in initial adherence (see below). Other investigators have stressed the importance of nonspecific factors in attachment. Cell surface hydrophobicity has been evaluated extensively (40, 76-78, 97, 139, 144, 160) . One group has claimed that measurement of hydrophobicity can predict the clinical significance of coagulase-negative staphylococcal clinical isolates better than any other laboratory test (124) . While hydrophobicity may play a role in adherence, there is marked variation in hydrophobicity, not only among different strains of coagulase-negative staphylococci (including slime-producing strains) but even over the surfaces of individual bacteria (77, 97, 160) . Moreover, hydrophobic strains vary considerably in their abilities to adhere to plastics (78) .
Other nonspecific determinants of the interaction between coagulase-negative staphylococci and the catheter surface polyvinyl chloride may include long-range forces (London-van der Waal's electromagnetic forces of attraction), the free energy of bacterial surfaces, and the hydrophobicity ("wetability") of the catheter surface (40) . The theory that hydrophilic catheters might be less prone to bacterial attachment has been particularly attractive to some manufacturers, although evidence that such plastics preserve their wetability in vivo or reduce the risk of infection is lacking.
Of course, any in vitro study of staphylococcal adherence to plastic catheters taken directly from the manufacturer's carton may not be relevant to the in vivo situation. Indeed, catheters are rapidly coated with host proteins such as fibrin, fibrinogen, and fibronectin once they are inserted into the vasculature (79, 145, 190) . S. aureus binds avidly to fibronectin (49, 71, 190, 191) , and there is considerable evidence that S. aureus infections of implanted foreign bodies are mediated by fibronectin. Thus, it has been tempting to speculate that adherence of coagulase-negative staphylococci also might be enhanced by proteins coating the catheter surface. Russell et al. found a modest increase in adherence of coagulase-negative staphylococci to polyvinyl chloride catheters that had been preincubated with fibronectin (165) , and Vaudaux noted slightly enhanced adherence to intravenous catheters of unspecified material that had been removed from patients. They attributed this enhanced adherence to fibronectin (191) . However, Pascual et al. de- tected no increased attachment to fibronectin-coated catheters (139) . Moreover, recent studies by our group demonstrated that adherence of coagulase-negative staphylococci was inhibited by coating silicon elastomer catheters with fresh blood, plasma, and serum and with purified fibrin, fibrinogen, and fibronectin (Fig. 5) (131) . The adherence of these coagulase-negative staphylococcal strains to Teflon catheters that had been inserted into volunteers for 5 min or 24 h was not significantly different from adherence to uninserted catheters; adherence of one of these three strains to catheters removed from patients was enhanced slightly (131) .
While acknowledging that coagulase-negative staphylococci may have nonspecific surface properties that promote adherence to plastics, our group has been interested in defining specific components of the cell surface that mediate initial adherence to catheter materials. As we explored the role of slime in the pathogenesis of catheter colonization, we discovered that a slime-producing strain of S. epidermidis (RP62A) widely used to study staphylococcal adherence expresses a specific polysaccharide capsular adhesin (PS/A) (185) . PS/A purified from strain RP62A and polyclonal and monoclonal antibodies raised against PS/A inhibited adherence of both the homologous strain and heterologous coagulase-negative staphylococcal strains to silicon elastomer tubing in a dose-response fashion (185) . Screening of a large number of S. epidermidis clinical isolates revealed that almost all expressed a serologically related PS/A and that adhesin expression correlated poorly with slime production (185) . Recently, Mack and his colleagues also described an S. epidermidis-associated polysaccharide that appears to mediate adherence and accumulation of cells on polymer surfaces (102) .
These observations suggested that immunotherapy directed specifically against PS/A might be of value in the prevention of infection caused by coagulase-negative staphylococci by inhibiting adherence to foreign bodies (93) . To investigate this possibility, we developed a rabbit model of intravenous catheter infection and bacteremia. Silicon elastomer catheters that had been dipped in an inoculum of PS/A-positive coagulase-negative staphylococci were inserted into the right jugular vein and kept open with heparin via a subcutaneous osmotic pump. Blood cultures were obtained for 8 days until the heparin in the pump was depleted. Nonimmune rabbits were bacteremic throughout the study period and had a strong immune response to teichoic acid but not to PS/A. PS/A immunization (in complete Freund's adjuvant), but not teichoic acid immunization, reduced bacteremia significantly and prevented the immune response to teichoic acid seen in infected animals. Passive infusion of PS/A-specific polyclonal and monoclonal antibodies via a separate, uncontaminated catheter in the left jugular vein protected against both bacteremia and hematogenous colonization of the contralateral catheter. Protection was also seen when rabbits were challenged with a heterologous strain. In subsequent experiments, we also found that active and passive immunoprophylaxis against PS/A prevented S. epidennidis endocarditis in a rabbit model (183) .
In these animal models, we were unable to determine whether protection was due to the antiadhesive properties of PS/A-specific antibody or to the opsonophagocytic effect of antibody on blood-borne coagulase-negative staphylococci. We speculated that PS/A might serve not only as a staphylococcal adhesin but also as a typical bacterial capsule, impairing host defense by interfering with phagocytic killing.
Although most investigators have lavished their attention on coagulase-negative staphylococcal slime and polysaccharide adhesins, some have started to explore the surface proteins of staphylococci. Patrick's group, for example, has identified 20 to 30 distinct proteins on the surface of coagulase-negative staphylococci; 5 to 10 of these proteins were immunogenic and were recognized by normal human sera (141 One additional adherence mechanism of S. epidennidis also deserves mention, although it probably is of minimal importance in catheter-related infections. When there is a preexisting fibrin-platelet clot (for example, on a prosthetic heart valve), S. epidermidis adherence may be mediated by lipoteichoic acid (27) . Conceivably, hematogenous seeding of the tips of indwelling intravascular catheters could be facilitated in this fashion.
Persistence, infection, and dissemination. As noted previously, many investigators have been intrigued by the abilities of some coagulase-negative staphylococcal strains, particularly those isolated from infected medical devices, to elaborate copious amounts of an extracellular material generally referred to as slime (20, 21, 24-26, 36, 38, 40, 52, 82, 94, 101, 105, 124, 144, 146, 158, 196) . Credit for the discovery of the importance of slime in the pathogenesis of coagulase-negative staphylococcal foreign-body infection probably should go to Bayston and Penny, who examined infected cerebrospinal fluid shunts under the microscope and noted that microcolonies of staphylococci imbedded in a mucoid layer adherent to the surface of shunt valves could be visualized (9) . Coagulase-negative staphylococci from these shunts produced a mucoid, slimy material that was thought to be a polysaccharide because it stained with alcian blue.
After a brief hiatus, investigation of the significance of slime production began in earnest, led by Christensen and his colleagues. These studies were facilitated by development of a simple macroscopic method for measuring slime production that was based on Christensen's observation that slime-producing strains left a film on the surfaces of plastic tubes that could be stained with alcian blue or safranin (24) . A more quantitative measurement of slime production has been obtained by using spectrophotometry to measure slime deposition in tissue culture wells (26, 38) or by measuring cell-associated urease activity (43 (25) , although recent work has failed to confirm these findings (140) . If slime is a true virulence factor, then when and how it has its effect were not clarified by these animal experiments.
In vitro and in vivo work has been hindered by a lack of isogenic mutants with stable expression or lack of expression of the virulence factors of interest. Christensen et al., for example, used a phenotypically weak slime producer rather than an isogenic slime-negative strain of coagulasenegative staphylococci in his experiments (25) . More recently, Christensen et al. reported a spontaneous mutant and an acriflavin mutant of S. epidermidis RP62A that did not produce slime and appeared to accumulate more slowly on plastic surfaces (22) . Our group has used transposon mutagenesis to obtain a slime-negative, PS/A-negative strain of S.
epidernidis that adheres poorly to silicon elastomer in comparison with its parent strain (132) .
If slime is involved in the pathogenesis of catheter-related infection, what, precisely, is its role? Examination of catheters exposed to slime-producing strains in vitro or removed from patients with catheter-associated infections suggests strongly that slime facilitates bacterial persistence and catheter colonization. Scanning electron micrographs of catheters dipped in suspensions of slime-producing strains of coagulase-negative staphylococci reveal that adherent staphylococci are coated with slime within a matter of hours (146) . Eighteen hours later, microcolonies of staphylococci are virtually invisible beneath a thick blanket of slime (Fig. 6) . Scanning electron micrographs of catheters removed from patients are equally compelling (52, 122) , although it is unclear whether the biofilm (sometimes referred to as glycocalyx) enveloping the staphylococci is derived primarily from the bacteria or from the host's bloodstream. Exuberant biofilm formation has also been seen on infected cardiac pacemaker leads and power packs (121) and on peritoneal dialysis catheters (123) . group did find that S. epidermidis incubated for 18 h on a catheter surface to promote elaboration of slime was more resistant to phagocytosis than organisms grown for 2 h in broth (88) , confirming the general principle that bacteria on a solid surface are more resistant to phagocytosis than freely suspended or planktonic organisms (87, 144) . Noble et al. have also described slime factors that appear to be inhibitory to the bactericidal activities of neutrophils (136, 137) .
In addition to its effect on neutrophil function, slime may interfere with lymphocyte activity (65, 66, 145) . For example, slime has been reported to inhibit T-and B-cell blastogenesis and immunoglobulin production. However, crude slime preparations were used in these experiments, and it is not clear whether the observed effects were due to slime itself or to the well-known immunomodulating properties of teichoic acid (19) , a prominent constituent of crude slime (80, 185) .
Slime also may impair the abilities of antibiotics to kill coagulase-negative staphylococci, particularly when microcolonies of staphylococci are imbedded in a thick biofilm on a catheter surface (2, 3, 4, 44, 46, 98) . A combination of factors may contribute to this reduced antibiotic effect.
Biofilm may act as a diffusion barrier, reducing the effective concentration of some antibiotics at their sites of action. In addition, antibiotics that have excellent MBCs when tested against log-phase broth cultures in the clinical laboratory may be much less active when faced with sessile, slowly growing, nutritionally deprived bacteria on a catheter surface. Accordingly, Costerton and others have suggested that routine laboratory testing is inappropriate for foreign-body infections and have proposed alternative testing systems that more closely mimic the interaction of antibiotics and bacteria in a biofilm (2, 4) . However, despite these theoretical considerations and some supporting experimental data, most bacterial intravascular catheter infections, especially if caused by coagulase-negative staphylococci, can be eradicated with a 10-to 14-day course of an antibiotic chosen on the basis of conventional susceptibility testing (186) .
Little is known about effective host defenses against catheter-associated infections caused by coagulase-negative staphylococci. As 
